In summary, FOXP3 is confirmed to have the capacity to suppress proto‐oncogene MYC in liver neoplasm by up‐regulating miR‐198 through binding to its promoter, while miR‐198 targets the 3′‐UTR of MYC mRNA to inhibit its translation. Here, MYC is linked to liver neoplasm.